对心房和心室联合生理节奏的实用方法的短期安全性和可行性:初始单中心体验
Keita Watanabe1, Moritz Nies1, William Whang1
1Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Heart rhythm O2
|July 10, 2024
概括
高右心房隔膜节奏是传统节奏的可行和安全的替代方案,使巴赫曼捆绑节奏在72%的患者中成为可能. 这种生理节奏策略可以经常与左捆分支区域节奏相结合.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 传统的右心房附属体节奏可以使传导障碍恶化.
- 巴赫曼捆绑节奏提供了一个更生理的替代方案.
研究的目的:
- 评估解剖学指导的右高心房隔膜节奏的可行性,有效性和安全性.
- 评估将巴克曼捆绑激活与左捆绑分支区域步调相结合.
主要方法:
- 一项对96名患者的回顾性研究,将生理节奏 (右上心脏隔膜和左束支部区域节奏) 与常规节奏 (右心脏附属体和右心室上角节奏) 进行比较.
- 在植入和随访时记录了基线特征,传感,节奏值和阻抗.
主要成果:
- 在72%的病例中,生理节奏实现了巴赫曼捆绑节奏,在94%的病例中实现了左捆绑分支区域节奏.
- 在手术或光镜时间方面没有显著差异.
- 在生理节奏组中观察到较高的心房节奏值和较低的p波.
- 在每组中都出现了一个与有关的并发症.
结论:
- 常规的右上心脏隔膜置是一个可行的和安全的替代方案,以传统的右心脏附属体节奏.
- 这种方法促进了巴赫曼捆绑节奏,可以与左捆绑分支区域节奏相结合.
相关概念视频
Pulse rhythm
1.7K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Special considerations while measuring pulse
1.0K
Assessing a patient's pulse is a fundamental skill in healthcare, but certain situations require special attention:
1.0K
Conduction System of the Heart
13.7K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.7K
Disturbances in Heart Rhythm
5.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Dysrhythmias VI: Management of Dysrhythmias
598
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598


